文献速递细菌感染、耐药与抗菌药物医院感染防控

碳青霉烯耐药对中低收入国家肠杆菌科血流感染结局的影响:PANORAMA多国前瞻性队列研究

Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study.
PubMed 文献 · Lancet Infect Dis · 2019-04-29

BACKGROUND: Low-income and middle-income countries (LMICs) are under-represented in reports on the burden of antimicrobial resistance.…

要点

  • 中低收入国家肠杆菌科血流感染中,碳青霉烯耐药与院内死亡风险增加独立相关。
  • 需加强中低收入国家碳青霉烯耐药肠杆菌感染的预防、诊断和治疗策略。

核心结论

  • 在中低收入国家,碳青霉烯耐药与肠杆菌科血流感染患者住院时间延长和死亡率增加相关。

研究设计与样本

  • 多国前瞻性队列研究,在孟加拉国、哥伦比亚、埃及、加纳、印度、黎巴嫩、尼泊尔、尼日利亚、巴基斯坦和越南的16个三级医院中心连续招募297例患者。
  • 纳入碳青霉烯敏感肠杆菌科(CSE)血流感染174例和碳青霉烯耐药肠杆菌科(CRE)血流感染123例,无年龄限制。
  • 采用逆概率加权比例子分布风险模型和多状态模型分析碳青霉烯耐药对出院存活、院内死亡和住院时间的影响。

主要发现

  • CSE血流感染 crude 死亡率为20%(35/174),CRE血流感染 crude 死亡率为35%(43/123)。
  • 多位点序列分型显示CRE与CSE菌株分属不同克隆群,重叠有限。

临床怎么用

  • 在中低收入国家,对肠杆菌科血流感染患者应关注碳青霉烯耐药风险,其与不良结局独立相关。
  • 碳青霉烯耐药肠杆菌科血流感染可导致住院时间延长和院内死亡风险增加,需优化预防、诊断和治疗策略。

局限性

  • 研究仅纳入三级医院患者,结果外推至其他医疗机构需谨慎。
  • 观察性设计不能完全排除残余混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Low-income and middle-income countries (LMICs) are under-represented in reports on the burden of antimicrobial resistance. We aimed to quantify the clinical effect of carbapenem resistance on mortality and length of hospital stay among inpatients in LMICs with a bloodstream infection due to Enterobacteriaceae. METHODS: The PANORAMA study was a multinational prospective cohort study at tertiary hospitals in Bangladesh, Colombia, Egypt, Ghana, India, Lebanon, Nepal, Nigeria, Pakistan, and Vietnam, recruiting consecutively diagnosed patients with carbapenem-susceptible Enterobacteriaceae (CSE) and carbapenem-resistant Entero-bacteriaceae (CRE) bloodstream infections. We excluded patients who had previously been enrolled in the study and those not treated with curative intent at the time of bloodstream infection onset. There were no age restrictions. Central laboratories in India and the UK did confirmatory testing and molecular characterisation, including strain typing. We applied proportional subdistribution hazard models with inverse probability weighting to estimate the effect of carbapenem resistance on probability of discharge alive and in-hospital death, and multistate modelling for excess length of stay in hospital. All patients were included in the analysis. FINDINGS: Between Aug 1, 2014, and June 30, 2015, we recruited 297 patients from 16 sites in ten countries: 174 with CSE bloodstream infection and 123 with CRE bloodstream infection. Median age was 46 years (IQR 15-61). Crude mortality was 20% (35 of 174 patients) for patients with CSE bloodstream infection and 35% (43 of 123 patients) for patients with CRE bloodstream infection. Carbapenem resistance was associated with an increased length of hospital stay (3·7 days, 95% CI 0·3-6·9), increased probability of in-hospital mortality (adjusted subdistribution hazard ratio 1·75, 95% CI 1·04-2·94), and decreased probability of discharge alive (0·61, 0·45-0·83). Multilocus sequence typing showed various clades, with marginal overlap between strains in the CRE and CSE clades. INTERPRETATION: Carbapenem resistance is associated with increased length of hospital stay and mortality in patients with bloodstream infections in LMICs. These data will inform global estimates of the burden of antimicrobial resistance and reinforce the need for better strategies to prevent, diagnose, and treat CRE infections in LMICs. FUNDING: bioMérieux.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Stewardson AJ, Marimuthu K, Sengupta S, et al. Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study. Lancet Infect Dis. 2019. PMID: 31047852. doi:10.1016/S1473-3099(18)30792-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。